Primovist MRI

DIAGNOSTIC_TEST2 trials

Sponsors

Bayer, University Health Network, Toronto

Conditions

Colorectal NeoplasmsHepatocellular CarcinomaNeoplasm Metastasis

Phase 4

Health Economic Evaluation of Primovist-enhanced Liver MRI

CompletedNCT00764621

BayerColorectal Neoplasms, Neoplasm Metastasis

Start: 2008-10-31End: 2010-11-30Updated: 2014-11-04

Unknown Phase

Evaluation of Gd-EOB-DTPA MRI for Detection and Characterization of Liver Nodules in Cirrhotic Patients Undergoing Liver Transplantation and Potential Impact on Transplant Eligibility

University Health Network, TorontoHepatocellular Carcinoma

Start: 2017-11-07End: 2021-12-31Target: 80Updated: 2021-04-19

Related Papers

Prospective evaluation of Gadoxetate-enhanced magnetic resonance imaging and computed tomography for hepatocellular carcinoma detection and transplant eligibility assessment with explant histopathology correlation

Cancer Imaging2023-02-254 citations

Randomized multicentre trial of gadoxetic acid-enhanced MRI<i>versus</i>conventional MRI or CT in the staging of colorectal cancer liver metastases

British journal of surgery2014-03-20138 citations